-
Target and asset review
The Challenge: TherapeutAix was approached by a small virtual biotech to review a target and asset that for a rare fibrotic disease. The company asked for specific…
-
Translational Strategy
The Challenge: A small, highly virtualized biotech had identified an attractive target in fibrotic diseases and needed a translational strategy…
-
Thoughts from the Extracellular Matrix Pharmacology Symposium
Last week the TherapeutAix team participated in the excellent Extracellular Matrix Pharmacology Symposium, hosted by our network partner Nordic Bioscience. This was a 2-day virtual event,…
-
Inhaled Drug Delivery to the Lung
The Challenge: TherapeutAix was approached by a small biotech company developing a device with the potential to enhance inhaled drug delivery to the…
-
TherapeutAix to attend the Extracellular Matrix Pharmacology Symposium
TherapeutAix is attending the Extracellular Matrix Pharmacology Symposium hosted by network partner Nordic Bioscience on March 24th – 25th. The online symposium will centre on…
